AMNEAL 506 (Indomethacin extended release 75 mg)

Pill imprint AMNEAL 506 has been identified as Indomethacin extended release 75 mg.

Indomethacin is used in the treatment of gout, acute; back pain; cluster headaches; ankylosing spondylitis; pain (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Indomethacin 75 mg is not a controlled substance under the Controlled Substance Act (CSA).

Indomethacin extended release

Imprint:

AMNEAL 506

Strength:

75 mg

Color:

Blue / Clear

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Nonsteroidal anti-inflammatory agents

Pregnancy Category:

C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation

CSA Schedule:

Not a controlled drug

Manufacturer:

Amneal Pharmaceuticals

National Drug Code (NDC):

65162-0506

Inactive Ingredients:

ammonia
ferrosoferric oxide
butyl alcohol
corn starch
alcohol
FD&C Blue No. 1
FD&C Green No. 3
FD&C Yellow No. 5
FD&C Red No. 40
gelatin
isopropyl alcohol
lactose monohydrate
potassium hydroxide
povidone
propylene glycol
shellac
sucrose
magnesium silicate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.